| I-58 Pauline Traynard Validation of non-compartmental analysis (NCA) and bioequivalence results of PKanalix with respect to Phoenix WinNonLin and SAS. Wednesday 09:45-11:15 |
| I-58 Pauline Traynard Validation of non-compartmental analysis (NCA) and bioequivalence results of PKanalix with respect to Phoenix WinNonLin and SAS. Wednesday 09:45-11:15 |